Genpharmasec Limited submitted a regulatory disclosure to BSE Limited on October 14, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure intimates a change in the name of the company's subsidiary.
The subsidiary's name has been changed from "GENPHARMASEC MIDDLE EAST DMCC" to "GENPHARMASEC MIDDLE EAST FZCO". This change was effected due to revised naming conventions introduced by the Dubai Multi Commodities Centre (DMCC), which require entities registered with DMCC to adopt the suffix "FZCO".
According to the enclosed Certificate of Suffix Change in Company Name, the subsidiary was originally formed as a company with limited liability under Registration No. DMCC197026 on May 16, 2023. The name change became effective from October 9, 2026.
The certificate confirms that the change was made in accordance with Law No. (3) of 2020 Concerning the Dubai Multi Commodities Centre. The disclosure states that this information will also be available on the company's website at www.genpharmasec.com.
The document was digitally signed by Mr. Sohan Chaturvedi, Whole Time Director & CFO (DIN: 09629728), on behalf of Genpharmasec Limited.